Literature DB >> 11822743

Effect of exogenous nitric oxide in experimental trichinellosis.

Edward Hadaś1, Monika Derda, Elzbieta Wandurska-Nowak.   

Abstract

Nitric oxide (NO) is a free radical that has been given much attention over the past few years. It has been nicknamed a "killer" and "mediator" due to its toxic and signaling properties. Apart from its regular physiological function, NO indirectly participates in infectious diseases. Our investigations showed that NO administered as a drug may involve higher histopathological changes in infected animals and can involve higher infection. This report seems to be the first presentation of the participation of NO reactive nitrogen intermediates in the morphological transformation of muscle cells in trichinellosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11822743     DOI: 10.1007/s004360100500

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  4 in total

1.  The impact of l-arginine supplementation on the enteral phase of experimental Trichinella spiralis infection in treated and untreated mice.

Authors:  Hanaa O Fadl; Noha M Amin; Hanaa Wanas; Shimaa Saad El-Din; Heba A Ibrahim; Basma Emad Aboulhoda; Nardeen Zakka Bocktor
Journal:  J Parasit Dis       Date:  2020-07-25

2.  Effect of nitric oxide releasing drugs on the intensity of infection during experimental trichinellosis in mice.

Authors:  Elzbieta Wandurska-Nowak; Edward Hadaś; Monika Derda; Waldemar Wojt
Journal:  Parasitol Res       Date:  2003-03-12       Impact factor: 2.289

3.  Proteomic analysis of the response of Trichinella spiralis muscle larvae to exogenous nitric oxide.

Authors:  Xiaoli Wang; Liang Li; Xing Wei; Yuanyuan Wang; Hui Zhang; Ao Shi; Tao Liu; Xiaodi Yang; Qiang Fang
Journal:  PLoS One       Date:  2018-06-05       Impact factor: 3.240

Review 4.  Nitric oxide and respiratory helminthic diseases.

Authors:  Antonio Muro; José-Luís Pérez-Arellano
Journal:  J Biomed Biotechnol       Date:  2010-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.